Phase II study of PS-341 [bortezomib] in metastatic breast cancer
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2007
At a glance
- Drugs Bortezomib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 06 Aug 2007 Status changed from suspended to completed.
- 19 Sep 2005 New trial record.